Skip to content
2000
image of Molecular Docking and Single-Cell RNA-Seq Analysis Identify PTGS2 as a Key Target of Osthole in the Oral Squamous Cell Carcinoma Microenvironment

Abstract

Introduction

This study investigates the therapeutic effects of Osthole and elucidates its mechanisms in oral squamous cell carcinoma (OSCC).

Materials and Methods

Differential expression analysis was performed, followed by nomogram construction, gene set enrichment analysis, and immune infiltration analysis. Molecular docking was conducted to evaluate binding interactions, and single-cell analysis was performed.

Results

PTGS2 was identified as a key candidate capable of binding with Osthole. Immune infiltration analysis revealed elevated levels of activated inflammatory cells in OSCC. Single-cell analysis further showed high PTGS2 expression in macrophages and mast cells.

Discussion

This study demonstrates PTGS2’s involvement in OSCC, highlighting its potential as both a biomarker and a therapeutic target.

Conclusion

Osthole can modulate OSCC by targeting PTGS2, providing a theoretical basis for OSCC management.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673421317251022072700
2026-01-08
2026-02-24

  • From This Site

    /content/journals/cmc/10.2174/0109298673421317251022072700
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Lu Y. Zheng Z. Yuan Y. Pathak J.L. Yang X. Wang L. Ye Z. Cho W.C. Zeng M. Wu L. The emerging role of exosomes in oral squamous cell carcinoma. Front. Cell Dev. Biol. 2021 9 628103 10.3389/fcell.2021.628103 33718365
    [Google Scholar]
  2. Feng X. Xiao L.I. Galectin 2 regulates JAK/STAT3 signaling activity to modulate oral squamous cell carcinoma proliferation and migration in vitro. Biocell 2024 48 5 793 801 10.32604/biocell.2024.048395
    [Google Scholar]
  3. Hou C. Cai H. Zhu Y. Huang S. Song F. Hou J. Development and validation of autophagy-related gene signature and nomogram for predicting survival in oral squamous cell carcinoma. Front. Oncol. 2020 10 558596 10.3389/fonc.2020.558596 33178587
    [Google Scholar]
  4. Siegel R.L. Miller K.D. Wagle N.S. Jemal A. Cancer statistics, 2023. CA Cancer J. Clin. 2023 73 1 17 48 10.3322/caac.21763 36633525
    [Google Scholar]
  5. Zhou Y. Gu J. Yu H. Chen F. Long C. Maihemuti M. Chen T. Zhang W. Screening and Identification of ESR1 as a target of icaritin in hepatocellular carcinoma: Evidence from bibliometrics and bioinformatic analysis. Curr. Mol. Pharmacol. 2024 17 e18761429260902 10.2174/0118761429260902230925044009 38239068
    [Google Scholar]
  6. Dong Y. Zhang L. Chang H. Regulation of exosomes-mediated circnr4a1 on chemoresistance and biological effects of oral squamous cell carcinoma cells. Lett. Drug Des. Discov. 2023 20 7 921 929 10.2174/1570180819666220610140616
    [Google Scholar]
  7. Niu Q. Sun Q. Bai R. Zhang Y. Zhuang Z. Zhang X. Xin T. Chen S. Han B. Progress of nanomaterials-based photothermal therapy for oral squamous cell carcinoma. Int. J. Mol. Sci. 2022 23 18 10428 10.3390/ijms231810428 36142341
    [Google Scholar]
  8. Weiße J. Rosemann J. Krauspe V. Kappler M. Eckert A.W. Haemmerle M. Gutschner T. RNA-Binding proteins as regulators of migration, invasion and metastasis in oral squamous cell carcinoma. Int. J. Mol. Sci. 2020 21 18 6835 10.3390/ijms21186835 32957697
    [Google Scholar]
  9. Yu H. Pan J. Zheng S. Cai D. Luo A. Xia Z. Huang J. Hepatocellular carcinoma cell-derived exosomal miR-21-5p induces macrophage M2 polarization by targeting RhoB. Int. J. Mol. Sci. 2023 24 5 4593 10.3390/ijms24054593 36902024
    [Google Scholar]
  10. Nocini R. Vianini M. Girolami I. Calabrese L. Scarpa A. Martini M. Morbini P. Marletta S. Brunelli M. Molteni G. Parwani A. Pantanowitz L. Eccher A. PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside. Clin. Exp. Dent. Res. 2022 8 3 690 698 10.1002/cre2.590 35593124
    [Google Scholar]
  11. Liu H. Dilger J.P. Different strategies for cancer treatment: Targeting cancer cells or their neighbors? Chinese journal of cancer research 2025 37 2 289 292 10.21147/j.issn.1000‑9604.2025.02.12
    [Google Scholar]
  12. Sonkin D. Thomas A. Teicher B.A. Cancer treatments: Past, present, and future. Cancer Genet. 2024 286-287 18 24 10.1016/j.cancergen.2024.06.002 38909530
    [Google Scholar]
  13. Su Y. Wang W. Wang Y. Wang C. Sun S. Zhu X. Dai X. Li S. Gao X. Qin K. Application and development of targeted fishing technology in natural product screening - A simple minireview. Curr. Pharm. Anal. 2024 20 4 231 240 10.2174/0115734129301241240429114323
    [Google Scholar]
  14. Liu Z. Zhang J. Liu J. Guo L. Chen G. Fang Y. Yang Y. Combining network pharmacology, molecular docking and preliminary experiments to explore the mechanism of action of FZKA formula on non-small cell lung cancer. Protein Pept. Lett. 2023 30 12 1038 1047 10.2174/0109298665268153231024111622 37962044
    [Google Scholar]
  15. Wang S. Fu J.L. Hao H.F. Jiao Y.N. Li P.P. Han S.Y. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol. Res. 2021 170 105728 10.1016/j.phrs.2021.105728 34119622
    [Google Scholar]
  16. Qiong L. Shuyao X. Shan X. Qian F. Jiaying T. Yao X. Hui L. Recent advances in the glycolytic processes linked to tumor metastasis. Curr. Mol. Pharmacol. 2024 17 e18761429308361 10.2174/0118761429308361240823061634 39225205
    [Google Scholar]
  17. Xu Z. Rasteh A.M. Dong A. Wang P. Liu H. Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: A machine-learning pharmacological study. Chin. Med. 2024 19 1 141 10.1186/s13020‑024‑01018‑5 39385284
    [Google Scholar]
  18. Liu H.R. Harnessing traditional medicine and biomarker-driven approaches to counteract Trichostatin A-induced esophageal cancer progression. World J. Gastroenterol. 2025 31 20 106443 10.3748/wjg.v31.i20.106443 40495945
    [Google Scholar]
  19. Hengrui L. An example of toxic medicine used in Traditional Chinese Medicine for cancer treatment. Journal of Traditional Chinese Medicine 2023 43 2 209 210 10.19852/j.cnki.jtcm.2023.02.001
    [Google Scholar]
  20. Zhang X. Qiu H. Li C. Cai P. Qi F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci. Trends 2021 15 5 283 298 10.5582/bst.2021.01318 34421064
    [Google Scholar]
  21. Lu K. Lin J. Jiang J. Osthole inhibited cell proliferation and induced cell apoptosis through decreasing CPEB2 expression via up-regulating miR-424 in endometrial carcinoma. J. Recept. Signal Transduct. Res. 2020 40 1 89 96 10.1080/10799893.2019.1710846 31971049
    [Google Scholar]
  22. Ashrafizadeh M. Mohammadinejad R. Samarghandian S. Yaribeygi H. Johnston T.P. Sahebkar A. Anti-Tumor effects of osthole on different malignant tissues: A review of molecular mechanisms. Anticancer. Agents Med. Chem. 2020 20 8 918 931 10.2174/1871520620666200228110704 32108003
    [Google Scholar]
  23. Song J. Ham J. Song G. Lim W. Osthole suppresses cell growth of prostate cancer by disrupting redox homeostasis, mitochondrial function, and regulation of tiRNAHisGTG. Antioxidants 2024 13 6 669 10.3390/antiox13060669 38929108
    [Google Scholar]
  24. Ye J. Sun D. Yu Y. Yu J. Osthole resensitizes CD133+ hepatocellular carcinoma cells to cisplatin treatment via PTEN/AKT pathway. Aging 2020 12 14 14406 14417 10.18632/aging.103484 32673286
    [Google Scholar]
  25. Jo M.J. Lee Y.J. Park C.W. Chung Y.B. Kim J.S. Lee M.K. Shin D.H. Evaluation of the physicochemical properties, pharmacokinetics, and in vitro anticancer effects of docetaxel and osthol encapsulated in methoxy poly(ethylene glycol)-b-Poly(caprolactone) polymeric micelles. Int. J. Mol. Sci. 2020 22 1 231 10.3390/ijms22010231 33379376
    [Google Scholar]
  26. Yang J. Zhu X. Jin M. Cao Z. Ren Y. Gu Z. Osthole induces cell cycle arrest and apoptosis in head and neck squamous cell carcinoma by suppressing the PI3K/AKT signaling pathway. Chem. Biol. Interact. 2020 316 108934 10.1016/j.cbi.2019.108934 31870840
    [Google Scholar]
  27. Kamal M.V. Damerla R.R. Parida P. Rao M. Belle V.S. Dikhit P.S. Palod A. Gireesh R. Kumar N.A.N. Expression ofPTGS2 along with genes regulatingVEGF signalling pathway and association with high-risk factors in locally advanced oral squamous cell carcinoma. Cancer Med. 2024 13 3 e6986 10.1002/cam4.6986 38426619
    [Google Scholar]
  28. Liu H. Karsidag M. Chhatwal K. Wang P. Tang T. Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers. PLoS One 2025 20 1 e0314745 10.1371/journal.pone.0314745 39820192
    [Google Scholar]
  29. Liu H. Dong A. Rasteh A.M. Wang P. Weng J. Identification of the novel exhausted T cell CD8+ markers in breast cancer. Sci. Rep. 2024 14 1 19142 10.1038/s41598‑024‑70184‑1 39160211
    [Google Scholar]
  30. Liu H. Li Y. Karsidag M. Tu T. Wang P. Technical and biological biases in bulk transcriptomic data mining for cancer research. J. Cancer 2025 16 1 34 43 10.7150/jca.100922 39744578
    [Google Scholar]
  31. Liu H. Li Y. Potential roles of cornichon family AMPA receptor auxiliary protein 4 (CNIH4) in head and neck squamous cell carcinoma. Cancer Biomark. 2022 35 4 439 450 10.3233/CBM‑220143 36404537
    [Google Scholar]
  32. Song Z. Yu J. Wang M. Shen W. Wang C. Lu T. Shan G. Dong G. Wang Y. Zhao J. CHDTEPDB: Transcriptome expression profile database and interactive analysis platform for congenital heart disease. Congenit. Heart Dis. 2023 18 6 693 701 10.32604/chd.2024.048081
    [Google Scholar]
  33. Yan S. Han Z. Wang T. Wang A. Liu F. Yu S. Xu L. Shen H. Liu L. Lin Z. Na M. Exploring the immune-related molecular mechanisms underlying the comorbidity of temporal lobe epilepsy and major depressive disorder through integrated data set analysis. Curr. Mol. Pharmacol. 2025 17 e18761429380394 10.2174/0118761429380394250217093030 39976098
    [Google Scholar]
  34. He M. Guo Y. Yu M. Lin C. Identification of a ubiquitination-related signature for ovarian cancer based on 101 combinations of machine learning methods. Curr. Proteomics 2024 22 5 543 560 10.2174/0115701646359714241209075043
    [Google Scholar]
  35. Zhang Q. Yu B. Zhang Y. Tian Y. Yang S. Chen Y. Wu H. Combination of single-cell and bulk RNA seq reveals the immune infiltration landscape and targeted therapeutic drugs in spinal cord injury. Front. Immunol. 2023 14 1068359 10.3389/fimmu.2023.1068359 36742334
    [Google Scholar]
  36. Li Q. Chu Y. Yao Y. Song Q. FAT4 mutation is related to tumor mutation burden and favorable prognosis in gastric cancer. Curr. Genomics 2024 25 5 380 389 10.2174/0113892029300694240612081006 39323626
    [Google Scholar]
  37. Yuan X. Zhou J. Zhou L. Huang Z. Wang W. Qiu J. Yang Q. Zhang C. Ma M. Apoptosis-related gene- mediated cell death pattern induces immunosuppression and immunotherapy resistance in gastric cancer. Front. Genet. 2022 13 921163 10.3389/fgene.2022.921163 35865012
    [Google Scholar]
  38. Xiao X. Liu Y. Huang Y. Zeng W. Luo Z. Identification of the NF-κB inhibition peptides in asthma from Pheretima aspergillum decoction and formula granules using molecular docking and dynamics simulations. Curr. Pharm. Anal. 2024 20 3 202 211 10.2174/0115734129298587240322073956
    [Google Scholar]
  39. Chen D. Xu L. Xing H. Shen W. Song Z. Li H. Zhu X. Li X. Wu L. Jiao H. Li S. Yan J. He Y. Yan D. Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. iMeta 2024 3 5 e238 10.1002/imt2.238 39429873
    [Google Scholar]
  40. Yin X. Yang B. Su M. Sun S. Wang H. Predictive Value of p62 protein in the recurrence of oral squamous cell carcinoma. Oncologie 2021 23 4 533 546 10.32604/oncologie.2021.018705
    [Google Scholar]
  41. Silva J.P.N. Pinto B. Monteiro L. Silva P.M.A. Bousbaa H. Combination therapy as a promising way to fight oral cancer. Pharmaceutics 2023 15 6 1653 10.3390/pharmaceutics15061653 37376101
    [Google Scholar]
  42. Miller K.D. Nogueira L. Devasia T. Mariotto A.B. Yabroff K.R. Jemal A. Kramer J. Siegel R.L. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 2022 72 5 409 436 10.3322/caac.21731 35736631
    [Google Scholar]
  43. Caruntu A. Yang S.F. Acero J. New insights for an advanced understanding of the molecular mechanisms in oral squamous cell carcinoma. Int. J. Mol. Sci. 2024 25 13 6964 10.3390/ijms25136964 39000073
    [Google Scholar]
  44. Ugartemendia L. Bravo R. Reuter M. Castaño M.Y. Plieger T. Zamoscik V. Kirsch P. Rodríguez A.B. SLC6A4 polymorphisms modulate the efficacy of a tryptophan-enriched diet on age-related depression and social cognition. Clin. Nutr. 2021 40 4 1487 1494 10.1016/j.clnu.2021.02.023 33743283
    [Google Scholar]
  45. Pappula A.L. Gibson L.N. Bouley R.A. Petreaca R.C. In silico analysis of a SLC6A4 G100V mutation in lung cancers. microPubl. Biol. 2022 2022 10.17912/micropub.biology.000645 36247322
    [Google Scholar]
  46. Tu Y. Yao S. Chen Q. Li W. Song Y. Zhang P. 5-Hydroxytryptamine activates a 5-HT/c-Myc/SLC6A4 signaling loop in non–small cell lung cancer. Biochim. Biophys. Acta, Gen. Subj. 2022 1866 4 130093 10.1016/j.bbagen.2022.130093 35066124
    [Google Scholar]
  47. Hashemi Goradel N. Najafi M. Salehi E. Farhood B. Mortezaee K. Cyclooxygenase-2 in cancer: A review. J. Cell. Physiol. 2019 234 5 5683 5699 10.1002/jcp.27411 30341914
    [Google Scholar]
  48. Bell C.R. Pelly V.S. Moeini A. Chiang S.C. Flanagan E. Bromley C.P. Clark C. Earnshaw C.H. Koufaki M.A. Bonavita E. Zelenay S. Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations. Nat. Commun. 2022 13 1 2063 10.1038/s41467‑022‑29606‑9 35440553
    [Google Scholar]
  49. Gong Z. Li Q. Shi J. Wei J. Li P. Chang C.H. Shultz L.D. Ren G. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment. Immunity 2022 55 8 1483 1500.e9 10.1016/j.immuni.2022.07.001 35908547
    [Google Scholar]
  50. Zheng W. Guo Y. Kahar A. Bai J. Zhu Q. Huang X. Li Y. Xu B. Jia X. Wu G. Zhang C. Zhu Y. RUNX1-induced upregulation of PTGS2 enhances cell growth, migration and invasion in colorectal cancer cells. Sci. Rep. 2024 14 1 11670 10.1038/s41598‑024‑60296‑z 38778047
    [Google Scholar]
  51. Callahan B.N. Kammala A.K. Syed M. Yang C. Occhiuto C.J. Nellutla R. Chumanevich A.P. Oskeritzian C.A. Das R. Subramanian H. Osthole, a natural plant derivative inhibits MRGPRX2 induced mast cell responses. Front. Immunol. 2020 11 703 10.3389/fimmu.2020.00703 32391014
    [Google Scholar]
  52. Afrin L.B. Ackerley M.B. Bluestein L.S. Brewer J.H. Brook J.B. Buchanan A.D. Cuni J.R. Davey W.P. Dempsey T.T. Dorff S.R. Dubravec M.S. Guggenheim A.G. Hindman K.J. Hoffman B. Kaufman D.L. Kratzer S.J. Lee T.M. Marantz M.S. Maxwell A.J. McCann K.K. McKee D.L. Menk Otto L. Pace L.A. Perkins D.D. Radovsky L. Raleigh M.S. Rapaport S.A. Reinhold E.J. Renneker M.L. Robinson W.A. Roland A.M. Rosenbloom E.S. Rowe P.C. Ruhoy I.S. Saperstein D.S. Schlosser D.A. Schofield J.R. Settle J.E. Weinstock L.B. Wengenroth M. Westaway M. Xi S.C. Molderings G.J. Diagnosis of mast cell activation syndrome: A global “consensus-2”. Diagnosis 2021 8 2 137 152 10.1515/dx‑2020‑0005 32324159
    [Google Scholar]
  53. Wang B. Zheng X. Liu J. Zhang Z. Qiu C. Yang L. Zhang L. Zhang Q. Gao H. Wang X. Osthole inhibits pancreatic cancer progression by directly exerting negative effects on cancer cells and attenuating tumor-infiltrating M2 macrophages. J. Pharmacol. Sci. 2018 137 3 290 298 10.1016/j.jphs.2018.07.007 30098910
    [Google Scholar]
  54. Fan H. Gao Z. Ji K. Li X. Wu J. Liu Y. Wang X. Liang H. Liu Y. Li X. Liu P. Chen D. Zhao F. The in vitro and in vivo anti-inflammatory effect of osthole, the major natural coumarin from Cnidium monnieri (L.) Cuss, via the blocking of the activation of the NF-κB and MAPK/p38 pathways. Phytomedicine 2019 58 152864 10.1016/j.phymed.2019.152864 30878874
    [Google Scholar]
  55. Jin Y. Qian J. Ju X. Bao X. Li L. Zheng S. Chen X. Xiao Z. Chen X. Zhu W. Li W. Wu W. Liang G. Osthole protects against acute lung injury by suppressing NF-κ B-dependent inflammation. Mediators Inflamm. 2018 2018 1 12 10.1155/2018/4934592 30057486
    [Google Scholar]
  56. Liu H. Weng J. Huang C.L.H. Jackson A.P. Voltage- gated sodium channels in cancers. Biomark. Res. 2024 12 1 70 10.1186/s40364‑024‑00620‑x 39060933
    [Google Scholar]
  57. Liu H. Weng J. Huang C.L.H. Jackson A.P. Is the voltage-gated sodium channel β3 subunit (SCN3B) a biomarker for glioma? Funct. Integr. Genomics 2024 24 5 162 10.1007/s10142‑024‑01443‑7 39289188
    [Google Scholar]
  58. Liu H. Hamaia S.W. Dobson L. Weng J. Hernández F.L. Beaudoin C.A. Salvage S.C. Huang C.L.H. Machesky L.M. Jackson A.P. The voltage-gated sodium channel β3 subunit modulates C6 glioma cell motility independently of channel activity. Biochim. Biophys. Acta Mol. Basis Dis. 2025 1871 6 167844 10.1016/j.bbadis.2025.167844 40245999
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673421317251022072700
Loading
Molecular Docking and Single-Cell RNA-Seq Analysis Identify PTGS2 as a Key Target of Osthole in the Oral Squamous Cell Carcinoma Microenvironment
Bentham Science Publishers ; https://doi.org/10.2174/0109298673421317251022072700
/content/journals/cmc/10.2174/0109298673421317251022072700
/content/journals/cmc/10.2174/0109298673421317251022072700
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: osthole ; molecular docking ; differentially expressed genes ; immune infiltration analysis ; single cell landscape ; Oral squamous cell carcinoma

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test